These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 14695213

  • 1. Butyrates, as a single drug, induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts.
    Gozzini A, Rovida E, Dello Sbarba P, Galimberti S, Santini V.
    Cancer Res; 2003 Dec 15; 63(24):8955-61. PubMed ID: 14695213
    [Abstract] [Full Text] [Related]

  • 2. Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts.
    Gozzini A, Santini V.
    Ann Hematol; 2005 Dec 15; 84 Suppl 1():54-60. PubMed ID: 16228241
    [Abstract] [Full Text] [Related]

  • 3. Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia.
    Ferrara FF, Fazi F, Bianchini A, Padula F, Gelmetti V, Minucci S, Mancini M, Pelicci PG, Lo Coco F, Nervi C.
    Cancer Res; 2001 Jan 01; 61(1):2-7. PubMed ID: 11196162
    [Abstract] [Full Text] [Related]

  • 4. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils.
    Ishihara K, Hong J, Zee O, Ohuchi K.
    Br J Pharmacol; 2004 Jul 01; 142(6):1020-30. PubMed ID: 15210580
    [Abstract] [Full Text] [Related]

  • 5. Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates.
    Qi H, Ratnam M.
    Cancer Res; 2006 Jun 01; 66(11):5875-82. PubMed ID: 16740727
    [Abstract] [Full Text] [Related]

  • 6. Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1.
    Tabe Y, Jin L, Contractor R, Gold D, Ruvolo P, Radke S, Xu Y, Tsutusmi-Ishii Y, Miyake K, Miyake N, Kondo S, Ohsaka A, Nagaoka I, Andreeff M, Konopleva M.
    Cell Death Differ; 2007 Aug 01; 14(8):1443-56. PubMed ID: 17464329
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells.
    Karasawa Y, Okisaka S.
    Jpn J Ophthalmol; 2004 Aug 01; 48(6):542-51. PubMed ID: 15592778
    [Abstract] [Full Text] [Related]

  • 8. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis.
    Chen J, Du C, Kang J, Wang J.
    Chem Biol Interact; 2008 Jan 10; 171(1):26-36. PubMed ID: 17961528
    [Abstract] [Full Text] [Related]

  • 9. Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins.
    Moldenhauer A, Frank RC, Pinilla-Ibarz J, Holland G, Boccuni P, Scheinberg DA, Salama A, Seeger K, Moore MA, Nimer SD.
    J Leukoc Biol; 2004 Sep 10; 76(3):623-33. PubMed ID: 15197237
    [Abstract] [Full Text] [Related]

  • 10. Deficient histone acetylation in acute leukemia and the correction by an isothiocyanate.
    Xiao L, Huang Y, Zhen R, Chiao JW, Liu D, Ma X.
    Acta Haematol; 2010 Sep 10; 123(2):71-6. PubMed ID: 20051681
    [Abstract] [Full Text] [Related]

  • 11. Myeloid transforming protein Evi1 interacts with methyl-CpG binding domain protein 3 and inhibits in vitro histone deacetylation by Mbd3/Mi-2/NuRD.
    Spensberger D, Vermeulen M, Le Guezennec X, Beekman R, van Hoven A, Bindels E, Stunnenberg H, Delwel R.
    Biochemistry; 2008 Jun 17; 47(24):6418-26. PubMed ID: 18500823
    [Abstract] [Full Text] [Related]

  • 12. Small molecule inhibitors of WNT signaling effectively induce apoptosis in acute myeloid leukemia cells.
    Minke KS, Staib P, Puetter A, Gehrke I, Gandhirajan RK, Schlösser A, Schmitt EK, Hallek M, Kreuzer KA.
    Eur J Haematol; 2009 Mar 17; 82(3):165-75. PubMed ID: 19067737
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of histone deacetylation enhances the neurotoxicity induced by the C-terminal fragments of amyloid precursor protein.
    Kim HS, Kim EM, Kim NJ, Chang KA, Choi Y, Ahn KW, Lee JH, Kim S, Park CH, Suh YH.
    J Neurosci Res; 2004 Jan 01; 75(1):117-24. PubMed ID: 14689454
    [Abstract] [Full Text] [Related]

  • 14. Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells.
    Nishioka C, Ikezoe T, Yang J, Koeffler HP, Yokoyama A.
    Leukemia; 2008 Dec 01; 22(12):2159-68. PubMed ID: 18784743
    [Abstract] [Full Text] [Related]

  • 15. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors.
    Bradbury CA, Khanim FL, Hayden R, Bunce CM, White DA, Drayson MT, Craddock C, Turner BM.
    Leukemia; 2005 Oct 01; 19(10):1751-9. PubMed ID: 16121216
    [Abstract] [Full Text] [Related]

  • 16. Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry.
    Naldi M, Andrisano V, Fiori J, Calonghi N, Pagnotta E, Parolin C, Pieraccini G, Masotti L.
    J Chromatogr A; 2006 Sep 29; 1129(1):73-81. PubMed ID: 16887128
    [Abstract] [Full Text] [Related]

  • 17. Response of retinoic acid-resistant KG1 cells to combination of retinoic acid with diverse histone deacetylase inhibitors.
    Savickiene J, Treigyte G, Magnusson KE, Navakauskiene R.
    Ann N Y Acad Sci; 2009 Aug 29; 1171():321-33. PubMed ID: 19723072
    [Abstract] [Full Text] [Related]

  • 18. Targeting aberrant transcriptional repression in acute myeloid leukemia.
    Moe-Behrens GH, Pandolfi PP.
    Rev Clin Exp Hematol; 2003 Jun 29; 7(2):139-59. PubMed ID: 14763160
    [Abstract] [Full Text] [Related]

  • 19. MS-275, a novel histone deacetylase inhibitor with selectivity against HDAC1, induces degradation of FLT3 via inhibition of chaperone function of heat shock protein 90 in AML cells.
    Nishioka C, Ikezoe T, Yang J, Takeuchi S, Koeffler HP, Yokoyama A.
    Leuk Res; 2008 Sep 29; 32(9):1382-92. PubMed ID: 18394702
    [Abstract] [Full Text] [Related]

  • 20. Involvement of the tumor necrosis factor (TNF)/TNF receptor system in leukemic cell apoptosis induced by histone deacetylase inhibitor depsipeptide (FK228).
    Sutheesophon K, Nishimura N, Kobayashi Y, Furukawa Y, Kawano M, Itoh K, Kano Y, Ishii H, Furukawa Y.
    J Cell Physiol; 2005 May 29; 203(2):387-97. PubMed ID: 15515013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.